Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab von Topp, B.G., Thiagarajan, K., De Alwis, D.P., Snyder, A., Hellmann, M.D.

Volltext

Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic von Kang, S.P., Gergich, K., Lubiniecki, G.M., de Alwis, D.P., Chen, C., Tice, M.A.B., Rubin, E.H.

Volltext

Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer von Chatterjee, M., Turner, D.C., Felip, E., Lena, H., Cappuzzo, F., Horn, L., Garon, E.B., Hui, R., Arkenau, H.-T., Gubens, M.A., Hellmann, M.D., Dong, D., Li, C., Mayawala, K., Freshwater, T., Ahamadi, M., Stone, J., Lubiniecki, G.M., Zhang, J., Im, E., De Alwis, D.P., Kondic, A.G., Fløtten, Ø.

Volltext

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients With Melanoma Treated With Pembrolizumab von Joseph, R.W., Elassaiss-Schaap, J., Kefford, R.F., Hwu, W.-J., Wolchok, J.D., Joshua, A.M., Ribas, A., Hodi, F.S., Hamid, O., Robert, C., Daud, A.I., Dronca, R.S., Hersey, P., Weber, J.S., Patnaik, A., Alwis, D.P. de, Perrone, A.M., Zhang, J., Kang, S.P., Ebbinghaus, S.W., Anderson, K.M., Gangadhar, T.

Volltext bestellen